Journal of Pharmacy and Pharmaceutical Sciences

Journal of Pharmacy and Pharmaceutical Sciences (JPPS) is a Canadian open-access, peer-reviewed scholarly journal devoted to pharmacy and pharmaceutical sciences. The journal was established in 1998 and is associated with the Canadian Society for Pharmaceutical Sciences. Its subject coverage spans the broad research and professional territory of pharmacy, including pharmaceutical development, drug delivery, pharmacology, pharmacokinetics, pharmaceutics, medicinal chemistry, clinical pharmacy, and related areas of biomedical and health research. The publication is intended for researchers, educators, health professionals, and other readers working across the pharmaceutical sciences rather than for a consumer audience. The journal's identity is built around accessible dissemination of scholarly work. As an open-access title, its articles are made available to readers without the subscription barriers associated with many traditional scientific journals. Its peer-review model positions the publication as a venue for research articles and other scholarly contributions evaluated by subject specialists. The journal's scope is therefore broader than a single therapeutic area or technical method: it connects laboratory pharmaceutical science with drug-use, clinical, and health-care applications. JPPS was established in 1998 under the editorship of Fakhreddin Jamali of the University of Alberta, who served as editor-in-chief from the journal's creation through 2025. This long editorial tenure provided continuity across multiple phases of pharmaceutical research, including the expansion of drug-delivery technologies, pharmacokinetic modeling, translational medicine, and evidence-based pharmacy practice. In 2025, Reza Mehvar of Chapman University became editor-in-chief, marking a leadership transition while retaining the journal's established pharmaceutical-science focus. The journal is published by Frontiers Media on behalf of the Canadian Society for Pharmaceutical Sciences. This publishing arrangement combines a society-linked scholarly identity with the infrastructure of an international academic publisher. The Canadian connection remains central to the title's institutional profile, while its open-access format and English-language research scope support readership and submissions beyond Canada. According to the cited Journal Citation Reports information, JPPS was classified as a first-quartile journal and had a 2025 impact factor of 5.5. Such metrics provide one indicator of the journal's citation visibility, although they do not by themselves describe the quality or significance of every individual article. Overall, JPPS is best understood as a specialist academic publishing brand: its principal offering is a continuing peer-reviewed journal, supported by editorial governance, scholarly review, digital distribution, and a broad pharmacy and pharmaceutical-science remit.

Journal of Pharmacy and Pharmaceutical Sciences was established in 1998 as an open-access, peer-reviewed journal serving the pharmacy and pharmaceutical-science community. Its remit covers the field broadly, rather than concentrating on one drug class, disease area, or research technique. The journal's subject territory includes pharmaceutical formulation and delivery, pharmacology, pharmacokinetics, medicinal chemistry, clinical pharmacy, and related biomedical research. From its establishment, the journal was led by Fakhreddin Jamali of the University of Alberta. Jamali served as editor-in-chief for the period 1998–2025, giving the title a long period of editorial continuity. During this period, pharmaceutical research developed across increasingly interdisciplinary areas, including advanced drug-delivery systems, quantitative pharmacology, translational therapeutics, and the integration of laboratory findings with clinical practice. JPPS's broad scope allowed it to remain relevant to these connected areas while retaining its identity as a pharmacy and pharmaceutical-science publication. The journal is associated with the Canadian Society for Pharmaceutical Sciences. Its Canadian institutional foundation is paired with an international publishing and readership model: the journal publishes in English, uses peer review, and makes its scholarly content openly accessible. The publication is described as being published by Frontiers Media on behalf of the Canadian Society for Pharmaceutical Sciences. This arrangement gives JPPS a society-affiliated scholarly profile while providing access to the systems and distribution capabilities of a major academic publisher. A significant editorial transition occurred in 2025, when Reza Mehvar of Chapman University succeeded Jamali as editor-in-chief. The change represents a new phase in the journal's governance but does not alter its core role as an open-access venue for pharmacy and pharmaceutical-science research. The journal remains active and continues to operate as a specialist academic publishing brand rather than as a pharmaceutical manufacturer, medicine brand, or health-care provider. The cited Journal Citation Reports information lists JPPS as a first-quartile journal and gives it a 2025 impact factor of 5.5. These indicators reflect the journal's citation position in the reported assessment period. Its continuing value, however, also rests on its disciplinary coverage, editorial process, society relationship, and open-access availability to researchers and professionals.

• 2025

  Editorial leadership changes

  [1]Journal of Pharmacy & Pharmaceutical Sciencesen.wikipedia.org

  Reza Mehvar became editor-in-chief after Fakhreddin Jamali's tenure, which had lasted from the journal's establishment through 2025.

• 2025

  Reported first-quartile status and impact factor

  [1]Journal of Pharmacy & Pharmaceutical Sciencesen.wikipedia.org

  The cited Journal Citation Reports information identifies the journal as Q1 and reports a 2025 impact factor of 5.5.

• 1998

  Journal established

  [1]Journal of Pharmacy & Pharmaceutical Sciencesen.wikipedia.org

  Journal of Pharmacy and Pharmaceutical Sciences was established as an open-access, peer-reviewed publication covering pharmacy and pharmaceutical sciences.

An open-access, peer-reviewed scholarly journal connecting pharmacy research, pharmaceutical science, and related biomedical applications, with a Canadian society affiliation and international academic reach.

• Open-access scholarly journal · 1998

  Journal of Pharmacy and Pharmaceutical Sciences

  The journal's principal offering is a continuing English-language, peer-reviewed publication covering the full breadth of pharmacy and pharmaceutical sciences. Its scholarly scope includes pharmaceutical research, drug development and delivery, pharmacology, pharmacokinetics, medicinal chemistry, clinical pharmacy, and related biomedical topics. The open-access model makes published research available to readers without conventional subscription access.

• 2025

  Editorial successionStrategy

  Background

  After more than two decades under founding editor-in-chief Fakhreddin Jamali, the journal reached an editorial transition point.

  Action taken

  Reza Mehvar of Chapman University assumed the editor-in-chief role.

  Aftermath

  The journal continued under new editorial leadership with its existing focus on open-access pharmacy and pharmaceutical-science research.

  Source

1. 1Journal of Pharmacy & Pharmaceutical Sciencesen.wikipedia.org
2. 2Official journal websiteualberta.ca